Guaifenesin / Pseudoephedrine
Guaifenesin/pseudoephedrine is a combination medicine that loosens chest congestion and relieves nasal and sinus congestion caused by the common cold, hay fever, and upper respiratory allergies.
🧬 Where this information comes from Click to expand
The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 54 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source. View the linked label on DailyMed →
📖 Guaifenesin / Pseudoephedrine: Patient Information Guide
A plain-language walkthrough of Guaifenesin / Pseudoephedrine — what it treats, how it works, how it’s taken, side effects, warnings and interactions. Tap any section to expand it.
🎯What it's used for▾
Guaifenesin/pseudoephedrine combines a chest decongestant (expectorant) with a nasal decongestant to address congestion from multiple angles. Supported uses across products include:
- Loosening phlegm and thinning bronchial secretions to make coughs more productive
- Temporarily relieving nasal congestion due to the common cold
- Temporarily relieving nasal congestion due to hay fever or other upper respiratory allergies
- Temporarily restoring freer breathing through the nose
- Promoting nasal and/or sinus drainage
- Temporarily relieving sinus congestion and pressure
- Poly-Vent IR tablet is also indicated for runny nose, sneezing, itching of the nose and throat, and itchy, watery eyes due to the common cold, hay fever, or upper respiratory allergies
💊How it's taken▾
The right dose and how often you take it depends on which product and strength you have — always check your product's label. Extended-release tablets (such as Equate Mucus D, Foster And Thrive Mucus Relief D, Guaifenesin and Pseudoephedrine HCl, and Guaifenesin D) are taken by mouth roughly every 12 hours and can be taken with or without food. Regular (immediate-release) tablets like Mucus Relief D film-coated tablet are taken every 4 hours with a full glass of water; Poly-Vent IR is also taken every 4 hours.
- Swallow extended-release tablets whole — never crush, chew, or break them
- Take all forms with a full glass of water
- Do not exceed the maximum number of doses listed on your specific product label in 24 hours
- If you miss a dose, follow your product label or ask your pharmacist; do not double up
🤒Side effects — in detail▾
This medicine is generally well tolerated, but pseudoephedrine is a stimulant and can cause:
- Nervousness or restlessness
- Dizziness
- Trouble sleeping
Stop use and contact a doctor right away if these symptoms are severe, if your congestion symptoms do not improve within 7 days or return, or if they come back alongside fever, rash, or a persistent headache — those could point to a more serious illness.
⚠️Warnings & precautions▾
The single most important warning: do not take this product if you currently use a prescription MAOI — or have taken one in the past 2 weeks. MAOIs are used for depression, certain psychiatric or emotional conditions, and Parkinson's disease. Combining pseudoephedrine with an MAOI can cause a serious, potentially dangerous reaction. If you're not certain whether one of your prescription medicines is an MAOI, ask your pharmacist before taking this product.
- Ask a doctor before use if you have heart disease, high blood pressure, thyroid disease, or diabetes — pseudoephedrine can affect all of these
- Ask a doctor if you have trouble urinating due to an enlarged prostate gland
- Ask a doctor if you have a persistent cough from smoking, asthma, chronic bronchitis, or emphysema, or a cough producing a large amount of mucus
- Stop use and ask a doctor if you become nervous, dizzy, or sleepless
- Stop use and ask a doctor if symptoms persist beyond 7 days, return, or occur with fever, rash, or a persistent headache
- Keep out of reach of children; in case of overdose, contact Poison Control immediately at 1-800-222-1222
🔀What it interacts with▾
The main drug interaction to know about involves MAOIs. Always tell your doctor or pharmacist about all medications you take.
- Prescription MAOIs (used for depression, psychiatric conditions, or Parkinson's disease) — do not use this product at the same time or within 2 weeks of stopping an MAOI; the combination can cause a serious reaction
This is not a complete list of interactions. Always talk with your doctor or pharmacist before starting, stopping, or changing any medication.
📋Before taking it▾
- Do not use if you currently take a prescription MAOI or have taken one in the past 2 weeks
- Check with a doctor first if you have heart disease
- Check with a doctor first if you have high blood pressure
- Check with a doctor first if you have thyroid disease
- Check with a doctor first if you have diabetes
- Check with a doctor first if you have trouble urinating due to an enlarged prostate gland
- Check with a doctor first if you have a chronic cough from smoking, asthma, chronic bronchitis, or emphysema
- Check with a doctor first if your cough produces a large amount of mucus
- If you are pregnant or breastfeeding, ask a health professional before use
- Most extended-release products: not for children under 12; Poly-Vent IR may be used in children 6 and older as directed, and children 2–5 should consult a doctor first
🚑If you take too much▾
If you or someone else takes too much, get medical help or contact Poison Control right away at 1-800-222-1222. Act immediately — do not wait for symptoms to appear.
📦How to store it▾
store between 20-25°C (68-77°F)
📄 Written from Guaifenesin / Pseudoephedrine’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Every point is grounded in that labeling — nothing is invented. How we use AI →
🩺 Pharmacist Counseling Corner
Quick, plain-English answers to the questions patients ask most about Guaifenesin / Pseudoephedrine — the kind of thing our pharmacy team would talk through with you at the counter.
What does this medicine actually do — do I need both ingredients? ▾
Can I crush or cut the extended-release tablet if it's hard to swallow? ▾
This product has pseudoephedrine in it — will it make me feel jittery or affect my sleep? ▾
I take an antidepressant. Is it safe to use this? ▾
How long before my symptoms should get better? ▾
I'm pregnant — is this safe to take? ▾
Is Guaifenesin / Pseudoephedrine available over the counter? ▾
When was Guaifenesin / Pseudoephedrine first available? ▾
Who makes Guaifenesin / Pseudoephedrine? ▾
💬 Answers drafted from Guaifenesin / Pseudoephedrine’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Grounded in that labeling — nothing is made up. How we use AI →
🧰 Keep exploring
💊 How Guaifenesin / Pseudoephedrine comes
Guaifenesin / Pseudoephedrine is available in 2 forms. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Extended-release tablet
How this form is used
- Helps loosen phlegm and thin bronchial secretions to make coughs more productive
- Temporarily relieves nasal congestion due to the common cold, hay fever, and upper respiratory allergies
- Temporarily restores freer breathing through the nose
- Promotes nasal and sinus drainage and temporarily relieves sinus congestion and pressure
- Do not crush, chew, or break extended-release tablets — swallow them whole
- Take with a full glass of water; may be taken with or without food
- Adults and children 12 and older: take as directed on your specific product label (frequency and number of tablets vary by product strength)
- Children under 12 years of age: do not use
Tablet
How this form is used
- Mucus Relief D: temporarily relieves sinus congestion and pressure, loosens phlegm, promotes nasal and sinus drainage, and relieves nasal congestion from cold, hay fever, or upper respiratory allergies
- Poly-Vent IR: temporarily relieves nasal congestion, runny nose, sneezing, itching of the nose and throat, and itchy watery eyes due to the common cold, hay fever, or upper respiratory allergies; also helps loosen phlegm to make coughs more productive
- Mucus Relief D (film-coated tablet): adults and children 12 and over take 1 tablet every 4 hours with a full glass of water while symptoms persist; do not exceed 6 tablets in 24 hours; children under 12 should not use
- Poly-Vent IR: adults and children 12 and over take 1 tablet every 4 hours, not to exceed 4 tablets in 24 hours; children 6 to under 12 may take ½ tablet every 4 hours, not to exceed 2 tablets in 24 hours; children 2 to under 6 should consult a doctor
📊 Guaifenesin / Pseudoephedrine across the U.S. market
How Guaifenesin / Pseudoephedrine appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
FDA-listed product records by dose form (tablet variants merged) — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
📈 How widely Guaifenesin / Pseudoephedrine is used
A general measure of how commonly Guaifenesin / Pseudoephedrine is prescribed, based on Medicaid — one of the largest public drug programs. The figure below is prescriptions filled in Q1–Q4 2025, summed across every form and brand of the drug.
Think of this as a proxy for how widely Guaifenesin / Pseudoephedrine is used, drawn from freely available public data. Medicaid is just one program — these numbers don’t include Medicare, other government coverage, or commercial and cash-pay prescriptions, so real-world use is higher than what’s shown here.
How commonly is Guaifenesin / Pseudoephedrine prescribed? Of the 1,596 medications we measure, Guaifenesin / Pseudoephedrine ranks #1,161 by Medicaid prescriptions — more than 27% of them.
Utilization by Guaifenesin / Pseudoephedrine product
Pick a product to see its own Medicaid numbers. Each chip is one clinical product — a specific strength & dosage form as defined by RxNorm — with brand-name and generic versions combined.
12 HR guaifenesin 600 MG / pseudoephedrine hydrochloride 60 MG Extended Release Oral Tablet Most dispensed
Summed across the 8 of 94 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1305603
12 HR guaifenesin 1200 MG / pseudoephedrine hydrochloride 120 MG Extended Release Oral Tablet
Summed across the 1 of 34 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1244675
Shares are of the Medicaid prescriptions shown here. Product grouping follows RxNorm (the National Library of Medicine’s drug terminology), so “one product” means one strength & dosage form regardless of manufacturer. Dollar figures are gross Medicaid reimbursement before mandatory rebates — rebates (often large, especially for brand-name drugs) are confidential, so actual net cost to Medicaid is lower than shown.
Source: Medicaid State Drug Utilization Data (CMS), aggregated by generic ingredient — summed across every NDC (all brands, strengths, salt forms and dosage forms) of Guaifenesin / Pseudoephedrine, and across all states and both fee-for-service and managed-care claims. A general popularity signal; it excludes Medicare, commercial insurance and cash prescriptions, so it is not total U.S. use. Based on the 9 of 128 listed Guaifenesin / Pseudoephedrine NDCs with Medicaid activity.
🔍 Compare Guaifenesin / Pseudoephedrine products
A representative set of FDA-listed product records for Guaifenesin / Pseudoephedrine — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Extended-release tablet | ||||
| GUAIFENESIN 600 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 60 mg | Oral | A-S Medication Solutions × 2 listings | NDA | View NDC → |
| 600; 60 mg/1; mg | Oral | A-S Medication Solutions × 3 listings | NDA | View NDC → |
| GUAIFENESIN 600 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 60 mg | Oral | Amerisource Bergen | ANDA | View NDC → |
| GUAIFENESIN 600 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 60 mg | — | Aurobindo Pharma Limited | DRUG FOR FURTHER PROCESSING | View NDC → |
| GUAIFENESIN 1200 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 120 mg | — | Aurobindo Pharma Limited | DRUG FOR FURTHER PROCESSING | View NDC → |
| GUAIFENESIN 600 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 60 mg | Oral | Aurohealth LLC | ANDA | View NDC → |
| GUAIFENESIN 1200 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 120 mg | Oral | Aurohealth LLC | ANDA | View NDC → |
| 600; 60 mg/1; mg | Oral | Aurohealth LLC × 2 listings | ANDA | View NDC → |
| 1200; 120 mg/1; mg | Oral | Aurohealth LLC × 2 listings | ANDA | View NDC → |
| 1200; 120 mg/1; mg | Oral | Cardinal Health | ANDA | View NDC → |
| GUAIFENESIN 600 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 60 mg | Oral | Cardinal Health 110, LLC. dba Leader | ANDA | View NDC → |
| GUAIFENESIN 1200 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 120 mg | Oral | Cardinal Health 110, LLC. dba Leader | ANDA | View NDC → |
| 600; 60 mg/1; mg | Oral | Cardinal Health 110, LLC. dba Leader × 2 listings | ANDA | View NDC → |
| GUAIFENESIN 600 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 60 mg | Oral | CVS Health Corp | ANDA | View NDC → |
| GUAIFENESIN 1200 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 120 mg | Oral | CVS Health Corp | ANDA | View NDC → |
| 600; 60 mg/1; mg | Oral | CVS Health Corp × 2 listings | ANDA | View NDC → |
| 1200; 120 mg/1; mg | Oral | CVS Health Corp × 2 listings | ANDA | View NDC → |
| GUAIFENESIN 1200 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 120 mg | Oral | CVS Pharmacy | ANDA | View NDC → |
| GUAIFENESIN 600 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 60 mg | Oral | CVS Pharmacy, Inc. | ANDA | View NDC → |
| GUAIFENESIN 600 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 60 mg | Oral | Cvs Woonsocket Prescription Center, Incorporated | ANDA | View NDC → |
| GUAIFENESIN 1200 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 120 mg | Oral | Cvs Woonsocket Prescription Center, Incorporated | ANDA | View NDC → |
| GUAIFENESIN 600 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 60 mg | — | Dr. Reddy's Laboratories Limited | DRUG FOR FURTHER PROCESSING | View NDC → |
| GUAIFENESIN 1200 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 120 mg | — | Dr. Reddy's Laboratories Limited | DRUG FOR FURTHER PROCESSING | View NDC → |
| GUAIFENESIN 600 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 60 mg | Oral | Dr. Reddys Laboratories Limited | ANDA | View NDC → |
| GUAIFENESIN 1200 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 120 mg | Oral | Dr. Reddys Laboratories Limited | ANDA | View NDC → |
| 600; 60 mg/1; mg | Oral | Dr. Reddys Laboratories Limited | ANDA | View NDC → |
| 1200; 120 mg/1; mg | Oral | Dr. Reddys Laboratories Limited | ANDA | View NDC → |
| GUAIFENESIN 600 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 60 mg | Oral | Granules India Ltd | ANDA | View NDC → |
| GUAIFENESIN 1200 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 120 mg | Oral | Granules India Ltd | ANDA | View NDC → |
| 600; 60 mg/1; mg | Oral | Granules India Ltd | ANDA | View NDC → |
| 1200; 120 mg/1; mg | Oral | Granules India Ltd | ANDA | View NDC → |
| 600; 60 mg/1; mg | Oral | Harris Teeter, LLC | ANDA | View NDC → |
| GUAIFENESIN 600 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 60 mg | Oral | H E B | ANDA | View NDC → |
| GUAIFENESIN 1200 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 120 mg | Oral | H E B | ANDA | View NDC → |
| 600; 60 mg/1; mg | Oral | H E B | ANDA | View NDC → |
| GUAIFENESIN 600 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 60 mg | Oral | Kroger Company × 2 listings | ANDA | View NDC → |
| 600; 60 mg/1; mg | Oral | Kroger Company × 2 listings | ANDA | View NDC → |
| GUAIFENESIN 600 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 60 mg | Oral | L. Perrigo Company | ANDA | View NDC → |
| GUAIFENESIN 1200 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 120 mg | Oral | L. Perrigo Company | ANDA | View NDC → |
| 1200; 120 mg/1; mg | Oral | LEADER/ Cardinal Health 110, Inc. | ANDA | View NDC → |
| GUAIFENESIN 600 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 60 mg | Oral | Meijer | ANDA | View NDC → |
| 600; 60 mg/1; mg | Oral | Meijer | ANDA | View NDC → |
| GUAIFENESIN 600 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 60 mg | Oral | Meijer, Inc. | ANDA | View NDC → |
| GUAIFENESIN 1200 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 120 mg | Oral | Meijer, Inc. | ANDA | View NDC → |
| 1200; 120 mg/1; mg | Oral | Meijer, Inc. | ANDA | View NDC → |
| 600; 60 mg/1; mg | Oral | Meijer Distribution Inc | ANDA | View NDC → |
| GUAIFENESIN 600 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 60 mg | Oral | Ohm Laboratories, Inc. | ANDA | View NDC → |
| GUAIFENESIN 1200 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 120 mg | Oral | Ohm Laboratories, Inc. | ANDA | View NDC → |
| 600; 60 mg/1; mg | Oral | Ohm Laboratories, Inc. | ANDA | View NDC → |
| 1200; 120 mg/1; mg | Oral | Ohm Laboratories, Inc. | ANDA | View NDC → |
| 600; 60 mg/1; mg | Oral | Ohm Laboratories Inc | NDA | View NDC → |
| 600; 60 mg/1; mg | Oral | Proficient Rx LP | ANDA | View NDC → |
| GUAIFENESIN 600 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 60 mg | Oral | Publix Super Markets, Inc | ANDA | View NDC → |
| GUAIFENESIN 1200 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 120 mg | Oral | Publix Super Markets Inc | ANDA | View NDC → |
| 600; 60 mg/1; mg | Oral | Publix Super Markets Inc | ANDA | View NDC → |
| 600; 60 mg/1; mg | Oral | RB Health (US) LLC | NDA | View NDC → |
| 1200; 120 mg/1; mg | Oral | RB Health (US) LLC | NDA | View NDC → |
| GUAIFENESIN 600 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 60 mg | Oral | Reckitt Benckiser LLC | NDA | View NDC → |
| GUAIFENESIN 1200 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 120 mg | Oral | Reckitt Benckiser LLC | NDA | View NDC → |
| 600; 60 mg/1; mg | Oral | Remedyrepack Inc. | NDA | View NDC → |
| GUAIFENESIN 600 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 60 mg | Oral | Rite Aid Corporation | ANDA | View NDC → |
| GUAIFENESIN 1200 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 120 mg | Oral | Rite Aid Corporation | ANDA | View NDC → |
| 600; 60 mg/1; mg | Oral | Rite Aid Corporation × 2 listings | ANDA | View NDC → |
| 1200; 120 mg/1; mg | Oral | Rite Aid Corporation × 2 listings | ANDA | View NDC → |
| GUAIFENESIN 600 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 60 mg | Oral | Rugby Laboratories | ANDA | View NDC → |
| 600; 60 mg/1; mg | Oral | Rugby Laboratories | NDA | View NDC → |
| 600; 60 mg/1; mg | Oral | Rugby Laboratories | ANDA | View NDC → |
| GUAIFENESIN 600 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 60 mg | Oral | Rugby Laboratories, Inc. | ANDA | View NDC → |
| 600; 60 mg/1; mg | Oral | Rugby Laboratories, Inc. | ANDA | View NDC → |
| GUAIFENESIN 600 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 60 mg | Oral | Strategic Sourcing Services, LLC | ANDA | View NDC → |
| 600; 60 mg/1; mg | Oral | Strategic Sourcing Services, LLC × 3 listings | ANDA | View NDC → |
| GUAIFENESIN 600 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 60 mg | Oral | Strategic Sourcing Services Llc × 4 listings | ANDA | View NDC → |
| GUAIFENESIN 1200 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 120 mg | Oral | Strategic Sourcing Services LLC | ANDA | View NDC → |
| 600; 60 mg/1; mg | Oral | Strategic Sourcing Services LLC | ANDA | View NDC → |
| GUAIFENESIN 600 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 60 mg | Oral | Topco Associates LLC | ANDA | View NDC → |
| 600; 60 mg/1; mg | Oral | Topco Associates LLC | ANDA | View NDC → |
| GUAIFENESIN 1200 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 120 mg | Oral | Wal-mart Stores, Inc. | ANDA | View NDC → |
| 1200; 120 mg/1; mg | Oral | Wal-mart Stores, Inc. × 2 listings | ANDA | View NDC → |
| 600; 60 mg/1; mg | Oral | Wal-Mart Stores Inc | ANDA | Find on DailyMed ↗ |
| GUAIFENESIN 600 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 60 mg | Oral | Walgreen Co. | ANDA | View NDC → |
| GUAIFENESIN 1200 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 120 mg | Oral | Walgreen Co. | ANDA | View NDC → |
| 600; 60 mg/1; mg | Oral | Walgreen Co. | ANDA | View NDC → |
| 1200; 120 mg/1; mg | Oral | Walgreen Co. × 2 listings | ANDA | View NDC → |
| GUAIFENESIN 600 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 60 mg | Oral | Walgreen Company | NDA | View NDC → |
| GUAIFENESIN 600 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 60 mg | Oral | Walgreen Company × 2 listings | ANDA | View NDC → |
| GUAIFENESIN 1200 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 120 mg | Oral | Walgreen Company | ANDA | View NDC → |
| 600; 60 mg/1; mg | Oral | Walgreen Company × 2 listings | ANDA | View NDC → |
| GUAIFENESIN 600 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 60 mg | Oral | Walgreens Company | ANDA | View NDC → |
| GUAIFENESIN 1200 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 120 mg | Oral | Walgreens Company | ANDA | View NDC → |
| 600; 60 mg/1; mg | Oral | Walgreens Company × 2 listings | ANDA | View NDC → |
| 1200; 120 mg/1; mg | Oral | Walgreens Company × 2 listings | ANDA | View NDC → |
| GUAIFENESIN 600 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 60 mg | Oral | Walmart Inc. | ANDA | View NDC → |
| GUAIFENESIN 1200 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 120 mg | Oral | Walmart Inc. | ANDA | View NDC → |
| 600; 60 mg/1; mg | Oral | Walmart Inc. | ANDA | View NDC → |
| 💊Tablet | ||||
| 400; 40 mg/1; mg | Oral | Chain Drug Marketing Association Inc | OTC MONOGRAPH FINAL | View NDC → |
| 400; 40 mg/1; mg | Oral | Chain Drug Marketing Association Inc | OTC MONOGRAPH DRUG | View NDC → |
| 600; 60 mg/1; mg | Oral | CVS Pharmacy | ANDA | Find on DailyMed ↗ |
| 200; 30 mg/1; mg | Oral | Dickey Consumer Products DBA DMD | OTC MONOGRAPH FINAL | Find on DailyMed ↗ |
| GUAIFENESIN 400 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 40 mg | Oral | Meijer Distribution Inc × 2 listings | OTC MONOGRAPH DRUG | View NDC → |
| 400; 40 mg/1; mg | Oral | Meijer Distribution Inc | OTC MONOGRAPH FINAL | View NDC → |
| 400; 40 mg/1; mg | Oral | Meijer Distribution Inc | OTC MONOGRAPH DRUG | View NDC → |
| GUAIFENESIN 380 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 60 mg | Oral | Poly Pharmaceuticals, Inc. | OTC MONOGRAPH DRUG | View NDC → |
| 380; 60 mg/1; mg | Oral | Poly Pharmaceuticals, Inc. | OTC MONOGRAPH FINAL | View NDC → |
| 380; 60 mg/1; mg | Oral | Poly Pharmaceuticals, Inc. | OTC MONOGRAPH DRUG | View NDC → |
| 600; 60 mg/1; mg | Oral | Rite Aid Corporation | ANDA | View NDC → |
| 400; 40 mg/1; mg | Oral | Walgreen Company | OTC MONOGRAPH FINAL | View NDC → |
| 400; 40 mg/1; mg | Oral | Walgreen Company | OTC MONOGRAPH DRUG | View NDC → |
| 375; 60 mg/1; mg | Oral | Xspire Pharma, Llc | OTC MONOGRAPH FINAL | Find on DailyMed ↗ |
Showing 132 of 132 products — FDA National Drug Code Directory. See every product, package size and price: browse all 132 Guaifenesin / Pseudoephedrine NDCs →
📈 What people report — real-world data (FDA FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Guaifenesin / Pseudoephedrine — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Guaifenesin / Pseudoephedrine in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
🏛️ The road to your pharmacy
How Guaifenesin / Pseudoephedrine went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
🚨 Recall history
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
Source: openFDA drug enforcement (recall) reports.
RxNorm Concept Web — From Ingredient to Every Form and Strength
This page starts with one exact multiple-ingredient concept (MIN). The branches below show its dose-form concepts (SCDF), then the available clinical drug and strength concepts (SCD). A product with a different ingredient combination belongs on a different page.
RxCUI 214599 4 dose forms · 16 strengths
-
Dose form (SCDF) Extended Release Oral Tablet RxCUI 373692In current FDA listingsClinical drug / strength (SCD) 12 HR guaifenesin 1200 MG / pseudoephedrine hydrochloride 120 MGRxCUI 124467512 HR guaifenesin 600 MG / pseudoephedrine hydrochloride 120 MGRxCUI 124469512 HR guaifenesin 600 MG / pseudoephedrine hydrochloride 60 MGRxCUI 130560312 HR guaifenesin 780 MG / pseudoephedrine hydrochloride 80 MGRxCUI 477585 -
Dose form (SCDF) Oral Capsule RxCUI 373687No current FDA listingClinical drug / strength (SCD) guaifenesin 150 MG / pseudoephedrine hydrochloride 30 MGRxCUI 1298405guaifenesin 200 MG / pseudoephedrine hydrochloride 30 MGRxCUI 1090482 -
Dose form (SCDF) Oral Solution RxCUI 373689No current FDA listingClinical drug / strength (SCD) guaifenesin 20 MG/ML / pseudoephedrine hydrochloride 6 MG/MLRxCUI 1089775guaifenesin 50 MG/ML / pseudoephedrine hydrochloride 7.5 MG/MLRxCUI 1099634 -
Dose form (SCDF) Oral Tablet RxCUI 373691In current FDA listingsClinical drug / strength (SCD) guaifenesin 190 MG / pseudoephedrine hydrochloride 30 MGRxCUI 1094003guaifenesin 360 MG / pseudoephedrine hydrochloride 60 MGRxCUI 2003123guaifenesin 375 MG / pseudoephedrine hydrochloride 60 MGRxCUI 1148644guaifenesin 380 MG / pseudoephedrine hydrochloride 60 MGRxCUI 1426579guaifenesin 400 MG / pseudoephedrine hydrochloride 20 MGRxCUI 1593149guaifenesin 400 MG / pseudoephedrine hydrochloride 30 MGRxCUI 1300020guaifenesin 400 MG / pseudoephedrine hydrochloride 40 MGRxCUI 1090623guaifenesin 400 MG / pseudoephedrine hydrochloride 60 MGRxCUI 1298443
Look up RxCUI 214599 in the RxCUI Atlas →
RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
📦 Supply & shortage status
Whether Guaifenesin / Pseudoephedrine is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
🏷️ Sold under these brand names
🏭 Manufacturers & labelers
…and 16 more on the FDA NDC directory.
RxNorm drug class
Guaifenesin / Pseudoephedrine belongs to the Expectorant class.
Classified by RxNorm RxClass — the U.S. National Library of Medicine's standardized drug-classification service (Established Pharmacologic Class from the FDA, the ATC drug family from the WHO, and mechanism of action). Reference only, not medical advice.
🔬 Where this comes from
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How we combine label and product data
HelloPharmacist combines public FDA and NLM records; we don’t author the underlying clinical facts. We identified 54 FDA-filed SPL label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. The representative label is the starting point for the displayed reference monograph; the 12 largest stored in-scope SPL records, which may include that representative, are compared section by section, and the longest available version of each section is retained. Forms, routes, brands, labelers, product-listed strengths, and product-record counts are aggregated separately from ingredient-matched FDA NDC Directory records; package records listed above are associated with the linked SPL; and the normalized concept hierarchy comes from NLM RxNorm.
For canonical ingredient pages, bounded product-attributed indication and administration excerpts may be added to the AI evidence, and the generator is instructed to preserve available product, brand, route, and form qualifiers instead of treating one label as universal. Where a section is identified as AI-written, its plain-language text is generated from bounded label evidence. New draft drug pages remain in the admin review queue before first publication. Walgreen Company is the representative DailyMed label linked for verification and dates; it is not the sole source used for the page.
This is general education, not medical advice — always consult your doctor or pharmacist about your medications and any medical condition. For the exact wording of the linked representative label, view that label on DailyMed; some displayed composite sections may come from other in-scope SPL labels. Learn how we use AI and our data sources & update cadence.